
DD Stock Forecast & Price Target
DD Analyst Ratings
Bulls say
DuPont de Nemours is supported by a clear earnings algorithm, as its ~12% Q3 EPS beat reflected broad-based organic growth, productivity gains, and margin expansion, while FY26 EPS guidance midpoint of $7.50 still implies about 22% y/y growth. Healthcare and Water are the core growth engines, with medical packaging, biopharma, and semiconductor/ultrapure water demand running strongly, and Water’s temporary Middle East delays appear more like timing issues than lost business. Diversified Industrials adds further upside through aerospace, EV battery revenues up ~60%, and 80/20 productivity initiatives, while low net leverage of 1.1x and strong free cash flow support buybacks and bolt-on M&A.
Bears say
DuPont de Nemours is pressured by a weak operating backdrop, with the downside case assuming delayed synergy realization, continued weakness in electronics, and slower recovery in China and North America. The company also faces ongoing integration and spin-optimization risks, plus further delays in separating its electronics businesses, while electronics and construction softness could weigh on its key profit engines. Even with healthcare and water expected to contribute most profits, the outlook remains negative because 2026E downside EPS is only $7.43 in one case and $7.20 in another, underscoring limited earnings resilience amid these risks.
This aggregate rating is based on analysts' research of DuPont de Nemours and is not a guaranteed prediction by Public.com or investment advice.
DD Analyst Forecast & Price Prediction
Start investing in DD
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About DuPont de Nemours (DD) Forecast
DD Analyst Forecast & Price Prediction
Start investing in DD
Order type
Buy in
Order amount
Est. shares
0 shares